TipRanks
Advertisement
Advertisement
Azitra Regains NYSE American Listing Compliance Status
PremiumCompany AnnouncementsAzitra Regains NYSE American Listing Compliance Status
2M ago
Azitra regains NYSE American compliance
Premium
The Fly
Azitra regains NYSE American compliance
2M ago
Azitra reports Q2 EPS (17c) vs. ($1.18) last year
Premium
The Fly
Azitra reports Q2 EPS (17c) vs. ($1.18) last year
2M ago
Azitra’s ATR12-351 Trial Completion Puts Rare-Disease Skin Drug on Investors’ Radar
PremiumCompany AnnouncementsAzitra’s ATR12-351 Trial Completion Puts Rare-Disease Skin Drug on Investors’ Radar
3M ago
Azitra announces results from two ex vivo human skin tissue studies
Premium
The Fly
Azitra announces results from two ex vivo human skin tissue studies
3M ago
Azitra Announces Strategic Shift Toward Cosmetics and Biotech Tools
Premium
Company Announcements
Azitra Announces Strategic Shift Toward Cosmetics and Biotech Tools
4M ago
Azitra granted new U.S. patent protecting ATR-12 program
PremiumThe FlyAzitra granted new U.S. patent protecting ATR-12 program
6M ago
Azitra Secures PIPE Financing to Advance Cosmetic Programs
Premium
Company Announcements
Azitra Secures PIPE Financing to Advance Cosmetic Programs
7M ago
Morning News Wrap-Up 3/20/26: Today’s Biggest Market Stories!
Premium
Market News
Morning News Wrap-Up 3/20/26: Today’s Biggest Market Stories!
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―